Sividon Diagnostics

The aim of Sividonl is the quality of companion diagnostics in oncology to improve their products sustainably.

Total raised

€0

Funding rounds

Investors

distinct backers

Active since

2011-08

latest 2011-08

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood16

base rate 44% for Seed

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2011-09-01	Seed	€0	Creathor Venture,KFW	View deal →

same sector or country